Breast Implants Linked To Rare Cancer, 9 Deaths, FDA Says

Law360, New York (March 22, 2017, 5:44 PM EDT) -- The U.S. Food and Drug Administration on Tuesday said that it’s received reports of nine deaths and about 360 cases of a rare type of blood cancer linked to breast implants, siding with the World Health Organization’s finding that the disease can develop after implantation.

Six years ago, the agency identified a possible connection between breast implants and the development of anaplastic large-cell lymphoma, a rare type of non-Hodgkin's lymphoma, but at the time the FDA knew of so few cases that it couldn’t determine a link.

Now, the FDA says that, while the exact number of cases is still difficult...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS